Financing, Equity Capital Markets
Fulcrum Therapeutics, Inc.
01/23
|
$125.0 Million
Âé¶¹´«Ã½ served as bookrunner for Fulcrum Therapeutics, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sector
Sub-Sector
Biopharma